Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-13

Clinical Trial Update: Self-management of Low Molecular Weight Heparin Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update on self-management of low molecular weight heparin therapy for venous thromboembolism; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2014-08-13